GB1260463A - 11beta-BROMO-19-NOR-STEROIDS - Google Patents

11beta-BROMO-19-NOR-STEROIDS

Info

Publication number
GB1260463A
GB1260463A GB456868A GB456868A GB1260463A GB 1260463 A GB1260463 A GB 1260463A GB 456868 A GB456868 A GB 456868A GB 456868 A GB456868 A GB 456868A GB 1260463 A GB1260463 A GB 1260463A
Authority
GB
United Kingdom
Prior art keywords
compositions
bromo
steroids
jan
hormonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB456868A
Other languages
English (en)
Inventor
Joseph Elks
Gordon Hanley Phillips
Alan Tulley
Leslie Stephenson
Margaret Elizabeth Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB456868A priority Critical patent/GB1260463A/en
Priority to NL6901340A priority patent/NL6901340A/xx
Priority to FR6901751A priority patent/FR2000922A1/fr
Priority to JP606069A priority patent/JPS4910502B1/ja
Priority to DE19691904323 priority patent/DE1904323A1/de
Priority to BE727577D priority patent/BE727577A/xx
Priority to CH138469A priority patent/CH543542A/de
Publication of GB1260463A publication Critical patent/GB1260463A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB456868A 1968-01-29 1968-01-29 11beta-BROMO-19-NOR-STEROIDS Expired GB1260463A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB456868A GB1260463A (en) 1968-01-29 1968-01-29 11beta-BROMO-19-NOR-STEROIDS
NL6901340A NL6901340A (pl) 1968-01-29 1969-01-28
FR6901751A FR2000922A1 (pl) 1968-01-29 1969-01-29
JP606069A JPS4910502B1 (pl) 1968-01-29 1969-01-29
DE19691904323 DE1904323A1 (de) 1968-01-29 1969-01-29 Bromsubstituierte Steroide und Verfahren zu ihrer Herstellung
BE727577D BE727577A (pl) 1968-01-29 1969-01-29
CH138469A CH543542A (de) 1968-01-29 1969-01-29 Verfahren zur Herstellung von in 9-Stellung unsubstituierten 11-B-Brom-19-nor-9a-steroiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB456868A GB1260463A (en) 1968-01-29 1968-01-29 11beta-BROMO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
GB1260463A true GB1260463A (en) 1972-01-19

Family

ID=9779606

Family Applications (1)

Application Number Title Priority Date Filing Date
GB456868A Expired GB1260463A (en) 1968-01-29 1968-01-29 11beta-BROMO-19-NOR-STEROIDS

Country Status (7)

Country Link
JP (1) JPS4910502B1 (pl)
BE (1) BE727577A (pl)
CH (1) CH543542A (pl)
DE (1) DE1904323A1 (pl)
FR (1) FR2000922A1 (pl)
GB (1) GB1260463A (pl)
NL (1) NL6901340A (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059139A1 (en) * 2001-01-24 2002-08-01 Schering Aktiengesellschaft Androgenic 7-substituted 11-halogen steroids

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002059139A1 (en) * 2001-01-24 2002-08-01 Schering Aktiengesellschaft Androgenic 7-substituted 11-halogen steroids
AU2002238516B2 (en) * 2001-01-24 2007-08-23 Schering Aktiengesellschaft Androgenic 7-substituted 11-halogen steriods
US7361645B2 (en) 2001-01-24 2008-04-22 Bayer Schering Pharma Ag Androgenic 7-substituted 11-halogen steroids
HRP20030661B1 (en) * 2001-01-24 2011-10-31 Bayer Pharma Aktiengesellschaft 11c-halogen steroids, their production and use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain 11c-halogen steroids
CZ303553B6 (cs) * 2001-01-24 2012-12-05 Schering Aktiengesellschaft 11beta-Halogenem substituované steroidy, použití techto steroidu a farmaceutická kompozice tyto steroidy obsahující

Also Published As

Publication number Publication date
BE727577A (pl) 1969-07-29
DE1904323A1 (de) 1969-09-25
CH543542A (de) 1973-10-31
JPS4910502B1 (pl) 1974-03-11
FR2000922A1 (pl) 1969-09-19
NL6901340A (pl) 1969-07-31

Similar Documents

Publication Publication Date Title
IL40376A0 (en) Pharmaceutical compositions containing an estrogenic and a progestational substance
IL34713A (en) Anaesthetic pharmaceutical preparations containing 3alpha-hydroxy-5alpha-pregnane 11,20-dione
GB1260463A (en) 11beta-BROMO-19-NOR-STEROIDS
GB1159434A (en) 11beta&;-Fluoro-19-nor-Steroids
MY6700093A (en) Styryl-pyridium compounds, the preparation thereof, and pharmaceutical compositions thereof
GB1260464A (en) 11beta-HALO-STEROIDS
IL36127A (en) 6alpha,9alpha-difluoro-11beta,21-dihydroxy-16alpha,17alpha-isopropylidenedioxy-pregna-1,4diene 21-esters,their preparation and pharmaceutical compositions containing them
IL32307A0 (en) New pregnane derivatives,their preparation and pharmaceutical compositions containing them
IL36654A0 (en) New oestrogenically highly active steroids of the estrane series,their manufacture and pharmaceutical compositions containing them
IL36608A (en) 16alpha,17alpha-dihydroxy-21-fluoro-pregna-4,6-diene-3,20-diones and derivatives thereof,their manufacture and pharmaceutical compositions containing them
IL32901A (en) Glycosidyl and glycuronosidyl steroids of the estrane series,preparation thereof and use as estrogenic agents
IL32935A0 (en) New pregnane and 19-nor-pregnane derivatives,their preparation and pharmaceutical compositions containing them
NL149815B (nl) Werkwijze voor het bereiden van steroide-verbindingen met oestrogene en progestatieve eigenschappen, alsmede daaruit gevormde geneesmiddelen.
AU269819B2 (en) Anew a-norb-homo steroid, processes for its preparation and pharmaceutical compositions thereof
AU1897162A (en) Anew a-norb-homo steroid, processes for its preparation and pharmaceutical compositions thereof
ZA703663B (en) Progestational composition and process for the preparation thereof
IL36397A0 (en) New n-vinyl-quinolones,processes for the preparation thereof and pharmaceutical compositions containing the same
GB1260465A (en) 11beta-CHLORO-19-NOR-STEROIDS
CA880871A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 6-METHYL-16-METHYLENE-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONE 17-ACETATE
CA921022A (en) Highly active oestrogenic steroid and process for its manufacture
CA545718A (en) 3-KETO ANDROSTANE AND PREGNANE COMPOUNDS BROMINATED IN .alpha.-POSITION TO THE KETO GROUP, AND PREPARATION
CA828741A (en) 3,3-DIMETHOXY 7.alpha.-METHYL 17.beta.-HYDROXY OU ALLYLOXY ESTRA-5(10),9(11)-DIENE
ZA711290B (en) Novel 16-methylene-9beta,10alpha steroid compounds,pharmaceutical preparations which contain the novel compounds as active ingredients,and methods of producing the said compounds and preparations
CA715539A (en) COMPOSITIONS CONTAINING 6.alpha.-FLUORO PREDNISOLONE AND 21-ACETATE
CA596004A (en) 21-BROMO-3.beta.,17.alpha.-DIHYDROXY-11,20-DIKETO PREGNANE AND ALLOPREGNANE AND PREPARATION

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees